Biography
Maiwenn Al obtained her Master degree in Mathematics at Leiden University in 1991. Since 1992 she has been working at the institute for Medical Technology Assessment (iMTA) at Erasmus University Rotterdam. From 1996 to 1999 she held a Pfizer Health Economics Fellowship and in 2001 she obtained her PhD degree at the Erasmus University Rotterdam. Her research focuses on modelling studies and methods for dealing with uncertainty in economic evaluations. Together with Ben van Hout, Maiwenn developed the cost-effectiveness acceptability curve, now widely used as a method to describe uncertainty around ICERs. Her most current research focuses on methods for censored data, including applications in the area of mental health care, and budget allocation models. The latter topic involves both theoretical models and a survey into the decision makers' view on health care objectives and budget constraints.
Erasmus School of Health Policy & Management
- al@eshpm.eur.nl
More information
Work
- Isaac Corro Ramos, Talitha L. Feenstra, Salah Ghabri & Maiwenn Al (2024) - Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling - PharmacoEconomics, 42 (7), 715-719 - doi: 10.1007/s40273-024-01364-0 - [link]
- Katharina Abraham, Tim Andre Kanters, Adrian Stuart Wagg, Nicole Huige, Edward Hutt & Maiwenn Johanna Al (2024) - Benefits of a digital health technology for older nursing home residents.: A de-novo cost-effectiveness model for digital health technologies to aid in the assessment of toileting and containment care needs - PLoS ONE, 19 (1 January) - doi: 10.1371/journal.pone.0295846 - [link]
- Amber Werbrouck, Esther de Bekker-Grob, Maiwenn Al, Koen Putman & Ruben Willems (2024) - Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation - Expert Review of Pharmacoeconomics and Outcomes Research, 24 (4), 551-557 - doi: 10.1080/14737167.2024.2324048 - [link]
- Philip Klein, Hedwig Blommestein, Maiwenn Al, Benedetta Pongiglione, Aleksandra Torbica & Saskia de Groot (2022) - Real-world evidence in health technology assessment of high-risk medical devices: Fit for purpose? - Health Economics (United Kingdom), 31 (S1), 10-24 - doi: 10.1002/hec.4575 - [link]
- Fernando Albuquerque de Almeida, Isaac Corro Ramos, Maiwenn Al & Maureen van Molken (2022) - Home Telemonitoring and a Diagnostic Algorithm in the Management of Heart Failure in the Netherlands: Cost-effectiveness Analysis - JMIR Cardio, 6 (2) - doi: 10.2196/31302 - [link]
- Marscha S. Holleman, Simone A. Huygens, Maiwenn J. Al, Malou C.P. Kuppen, Hans M. Westgeest, Alfonsus C.M. van den Bergh, Andries M. Bergman, Alfonsus J.M. van den Eertwegh, Mathijs P. Hendriks, Menuhin I. Lampe, Niven Mehra, Reindert J.A. van Moorselaar, Inge M. van Oort, Diederik M. Somford, Ronald de Wit, Agnes J. van de Wouw, Winald R. Gerritsen & Carin A.Uyl de Groot (2022) - Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer - Drugs - Real World Outcomes, 9 (2), 275-285 - doi: 10.1007/s40801-022-00294-7 - [link]
- Fernando Albuquerque de Almeida, Isaac Corro Ramos, Maureen Rutten-van Mölken & Maiwenn Al (2021) - Modeling Early Warning Systems: Construction and Validation of a Discrete Event Simulation Model for Heart Failure - Value in Health, 24 (10), 1435-1445 - doi: 10.1016/j.jval.2021.04.004 - [link]
- N Armstrong, Nasuh Buyukkaramikli, Hannah Penton, R Riemsma, Pim Wetzelaer, V Huertas Carrera, SL Swift, T Drachen, H Raatz, S Ryder, D Shah, T Buksnys, G Worthy, S Duffy, Maiwenn Al & J Kleijnen (2020) - Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis - Health Technology Assessment, 51, 1-220 - doi: 10.3310/hta24510.
- Fernando Albuquerque de Almeida, Maiwenn Al, R Koymans, J Riistame, S Pauws & Hans Severens (2020) - Impact of hospitalisation on health-related quality of life in patients with chronic heart failure - Health and Quality of Life Outcomes, 18 (1) - doi: 10.1186/s12955-020-01508-8 - [link]
- Marscha S Holleman, Harm van Tinteren, Harry Jm Groen, Maiwenn J Al & Carin A Uyl-de Groot (2019) - First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis - OncoTargets and Therapy, 12, 1413-1421 - doi: 10.2147/ott.S189438 - [link]
Advanced Research Methods
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4003MV
Master HEPL-HE 2024-2025
- Year
- 2024
- Course Code
- GWMTTHEPL
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4555M
Master Thesis HE
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4592M
Advanced Health Economic Modelling EuHEM
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4587M
Advanced Research Methods
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4588M
Advanced Health Economic Modelling
- Year Level
- master, master, master
- Year
- 2024
- Course Code
- GW4563M